Holen Sie sich die Stockscreener-App
54.14
2.81%
1.48
Handel nachbörslich:
54.14
Finanzdaten der Moonlake Immunotherapeutics-Aktie (MLTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
27.83%
60.70
|
47.48 | 49.58 | 43.11 | - |
| Operating Income/Loss |
27.83%
-60.70
|
-47.48 | -49.58 | -43.11 | - |
| Income/Loss From Continuing Operations Before Tax |
37.96%
-55.96
|
-40.56 | -46.35 | -36.02 | -24.76 |
| Income Tax Expense/Benefit |
37.91%
0.095
|
0.153 | 0.0411 | 0.0921 | - |
| Income/Loss From Continuing Operations After Tax |
38.20%
-56.05
|
-40.56 | -46.40 | -36.11 | -24.76 |
|
Net Income/Loss
|
38.20%
-56.05
|
-40.56 | -46.40 | -36.11 | -24.76 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
35.12%
-0.831
|
-0.615 | -0.7912 | -0.7241 | - |
| Basic Average Shares |
0.08%
63.28
|
63.23 | 0.067 | 62.90 | - |
| Diluted Average Shares |
0.08%
63.28
|
63.23 | 0.067 | 62.90 | - |
| Basic Earnings Per Share |
38.10%
-0.87
|
-0.63 | -0.72 | -0.56 | - |
| Diluted Earnings Per Share |
38.10%
-0.87
|
-0.63 | -0.72 | -0.56 | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.44%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):